NCT04011709View on ClinicalTrials.gov

A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

February 20, 2018

Study Completion Date

February 20, 2018

Conditions
CoughWheezing
Interventions
COMBINATION_PRODUCT

VR647 Inhalation System + VR647 Smart Card 3 Secs

3 attempts of 19 inhalations, 3 second per breath. Attempts 1 and 2 will be made with air only. Attempt 3 will be made with isotonic saline (0.9% NaCl)

COMBINATION_PRODUCT

VR647 Inhalation System + VR647 Smart Card 2 Secs

3 attempts of 28 inhalations, 2 second per breath. Attempts 1 and 2 will be made with air only. Attempt 3 will be made with isotonic saline (0.9% NaCl)

COMBINATION_PRODUCT

VR647 Inhalation System + VR647 Smart Card 4 Secs

3 attempts of 14 inhalations, 4 second per breath. Attempts 1 and 2 will be made with air only. Attempt 3 will be made with isotonic saline (0.9% NaCl)

Trial Locations (5)

27607

North Carolina Clinical Research, Raleigh

29407

National Allergy and Asthma Research, LLC, Charleston

55441

Clinical Research Institute, Inc, Plymouth

63110

St. Louis Children's Hospital, St Louis

92691

Allergy & Asthma Associates of Southern California, Mission Viejo

All Listed Sponsors
lead

Vectura Limited

INDUSTRY

NCT04011709 - A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy | Biotech Hunter | Biotech Hunter